Qube Research & Technologies (QRT)’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,663
Closed -$31.1K 4929
2024
Q1
$31.1K Buy
+5,663
New +$32.7K ﹤0.01% 3607
2022
Q1
Sell
-25,974
Closed -$252K 3146
2021
Q4
$252K Buy
25,974
+3,841
+17% +$37.4K ﹤0.01% 1878
2021
Q3
$215K Hold
22,133
﹤0.01% 1631
2021
Q2
$215K Buy
+22,133
New +$217K ﹤0.01% 1755

Other funds holding AONC

Qube Research & Technologies (QRT)'s AONC Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q2 2024, closing a stake of 5,663 shares — an estimated $31.1K sold.

Qube Research & Technologies (QRT) first reported a position in AONC in Q2 2021 and held it in 4 quarters. The position peaked at $252K in Q4 2021. 2 funds tracked by Wall St. Rank hold AONC as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 5,663 American Oncology Network, Inc. Class A Common Stock shares in Q2 2024, an estimated $31.1K.
  • Qube Research & Technologies (QRT) first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s American Oncology Network, Inc. Class A Common Stock position peaked at $252K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.